NCT00909337: Early Therapy of Pulmonary Arterial Hypertension |
|
|
| Completed | N/A | 10 | Europe | Bosentan, Tracleer | Medical University of Graz, Actelion | Pulmonary Hypertension, Systemic Sclerosis | 06/10 | 06/10 | | |
NCT01738542: Safety and Efficacy Study of Bosentan for Intermittent Claudication in Peripheral Arterial Disease |
|
|
| Completed | N/A | 30 | Europe | Bosentan, Tracleer, Antiaggregant therapy, Statins, Antihypertensive therapy | Hospital Universitario Getafe | Peripheral Arterial Disease | 11/10 | 11/10 | | |
Aspire, NCT01266265: Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies |
|
|
| Completed | N/A | 1333 | US | inhaled prostacyclin, treprostinil, iloprost, Ventavis, prostacyclin, epoprostenol sodium, Flolan, subcutaneous and intravenous prostacyclin, treprostinil , Remodulin, oral ERA, bosentan, Tracleer, ambrisentan, Letairis, oral PDE5 inhibitors, sildenafil, Revatio, tadalafil, Adcirca | United Therapeutics | Pulmonary Arterial Hypertension | 12/14 | 12/14 | | |
